tiprankstipranks
Engene Holdings Inc. (ENGN)
NASDAQ:ENGN
US Market

Compare enGene Holdings (ENGN) vs. Competitors

304 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
enGene Holdings
$7.27
$487.01M
-5.39
80.40%
6 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$2.96
$27.77M
-1.75
-79.86%
4 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$31.61
$1.82B
-12.77
236.28%
8 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$5.91
$488.00M
-3.16
-19.15%
0 Buy
3 Hold
0 Sell
Hold
Immuneering
$5.66
$365.94M
-5.17
338.76%
5 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$12.83
$497.25M
-5.28
177.71%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ENGN
enGene Holdings
7.27
3.27
81.75%
TVRD
Tvardi Therapeutics
2.96
-11.63
-79.71%
CAPR
Capricor Therapeutics
31.61
22.73
255.97%
REPL
Replimune Group
5.91
-1.01
-14.60%
IMRX
Immuneering
5.66
4.42
356.45%
CTNM
Contineum Therapeutics, Inc. Class A
12.83
8.70
210.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts